Marketplace

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

4150 of 1471
29DSC_6753UCSanDiegoPublicationsErikJepsenLG.jpg
  • Embargo expired:
    5-Sep-2018 8:00 AM EDT

Article ID: 699927

UC San Diego and Deerfield Management Create Poseidon Innovation to Advance Disease-Curing Therapeutics

University of California San Diego

University of California San Diego and Deerfield Management announce today the creation of Poseidon Innovation, LLC to advance disease-curing therapeutics. Through Deerfield’s $65-million commitment in Poseidon, UC San Diego investigators will have the funding and support to weather risky early-stage processes and expedite the drug-development cycle, allowing patients to receive treatment faster.

Released:
4-Sep-2018 1:15 PM EDT

Education

jared_elliot_nyc_demo_day_oct_2017.jpeg

Article ID: 699706

ORNL researchers enable real-time forensic analysis with new cybersecurity tool

Oak Ridge National Laboratory

Researchers at ORNL have developed a new cybersecurity tool called Akatosh that automates the process of analyzing computer networks to detect malware. The tool collects historical information on host systems on the network to immediately show changes that transpired leading up to and during a cyber attack, which saves precious time and resources previously spent manually searching the network for changes.

Released:
29-Aug-2018 10:30 AM EDT
WoltersKluwer_CMYK-ol.jpg

Article ID: 699644

Wolters Kluwer and the Family Physicians Inquiries Network Enter Publishing Partnership

Wolters Kluwer Health: Lippincott Williams and Wilkins

Wolters Kluwer Health announced today it will begin electronic publishing of Evidence-Based Practice, the official journal of the Family Physicians Inquiries Network (FPIN). The monthly journal, which focuses on topics relevant to the daily practice of family medicine, will be curated in the Lippincott portfolio beginning in September 2018.

Released:
28-Aug-2018 11:05 AM EDT
New Logo.png

Article ID: 699169

UChicago Medicine, Humana Sign Value-Based Care Agreement to Offer Enhanced Patient Experience for Humana Medicare Advantage Members

University of Chicago Medical Center

The University of Chicago Medicine and Humana Inc. have entered into a value-based agreement designed to offer a coordinated, patient-centered experience to help Humana Medicare Advantage members achieve their best health.

Released:
23-Aug-2018 11:00 AM EDT

Article ID: 699426

Dthera Sciences Receives FDA Breakthrough Device Designation For Its Alzheimer's Focused Development-Stage Product "DTHR-ALZ"

Dthera Sciences

Dthera™ Sciences (OTCQB:DTHR), the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.

Released:
23-Aug-2018 10:40 AM EDT

Article ID: 699204

The Book That Will Bring Objective Strength Measurement to Therapy

MET

MET is pleased to announce the forthcoming (August 20th) launch of their book Hand-Held Dynamometry: Guidelines for Daily Clinical Practice written by physical therapist Dr. Frank Aerts and occupational therapist Becky Alwood.

Released:
20-Aug-2018 5:00 AM EDT
Aconity3D.jpg

Article ID: 698630

Aconity3D, Emerging Tech Leader in Laser-Based Additive Manufacturing, to Make Home at UTEP

University of Texas at El Paso

The University of Texas at El Paso will serve as the North American base of operations for Aconity3D, one of the world’s emerging technology leaders in the production of 3D printing equipment, under a new agreement announced by the two organizations this summer.

Released:
7-Aug-2018 4:30 PM EDT
and-logo.jpg
  • Embargo expired:
    6-Aug-2018 4:15 PM EDT

Article ID: 698588

MD Anderson and Jazz Pharmaceuticals collaborate to evaluate potential treatment options for hematologic malignancies

University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year collaboration agreement with a goal of evaluating therapies for multiple hematologic malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes.

Released:
6-Aug-2018 9:00 AM EDT

Showing results

4150 of 1471

Chat now!